RE:New Press Release - Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023This data is phenomenal!!!!!!!! Congrats PMN!
https://d1io3yog0oux5.cloudfront.net/_2a4309c96d878f12712eab5f8da7dca2/promisneurosciences/db/1004/8780/pdf/PMN310+Poster+Presentation+P0214+at+ADPD+2023.pdf